Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland. monica.d'
Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland.
Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):741-750. doi: 10.1158/1055-9965.EPI-18-0887. Epub 2019 Jan 30.
Allergic conditions may prevent some cancers by promoting immune surveillance. We examined associations of allergic rhinitis, asthma, and eczema with cancer risk among elderly Americans.
We used Surveillance Epidemiology and End Results (SEER)-Medicare linked data to perform a case-control study. Cases were individuals with first cancer diagnosed in SEER registries (1992-2013, ages 66-99; = 1,744,575). Cancer-free controls ( = 100,000) were randomly selected from Medicare and matched on sex, age, and selection year. Allergic conditions were identified using Medicare claims, and logistic regression was used to estimate adjusted ORs (aOR) with significance gauged with a Bonferroni cutoff ( < 0.00034).
Allergic rhinitis, asthma, and eczema were present in 8.40%, 3.45%, and 0.78% of controls, respectively. For allergic rhinitis, strong inverse associations (aORs, 0.66-0.79) were observed for cancers of the hypopharynx, esophagus (squamous cell), cervix, tonsil/oropharynx, and vagina/vulva. More modest but significant inverse associations were noted for cancers of the esophagus (adenocarcinoma), stomach, colon, rectosigmoid/rectum, liver, gallbladder, lung, uterus, bladder, and miscellaneous sites. Associations were stronger in analyses requiring a dispensed medication to confirm the presence of allergic rhinitis. Asthma was associated with reduced risk of liver cancer [aOR 0.82; 95% confidence interval (CI), 0.75-0.91], whereas eczema was associated with elevated risk of T-cell lymphoma (aOR, 4.12; 95% CI, 3.43-4.95).
Inverse associations with allergic rhinitis are present for multiple cancers and require etiologic investigation.
Understanding of mechanisms by which allergic conditions reduce cancer risk may advance cancer prevention and treatment.
过敏症可能通过促进免疫监视来预防某些癌症。我们研究了老年人群中过敏性鼻炎、哮喘和湿疹与癌症风险之间的关系。
我们使用监测、流行病学和最终结果(SEER)-医疗保险关联数据进行病例对照研究。病例是在 SEER 登记处首次诊断出癌症的个体(1992-2013 年,年龄 66-99 岁;n=1744575)。从医疗保险中随机选择无癌症的对照(n=100000),并按性别、年龄和选择年份进行匹配。过敏症使用医疗保险索赔来确定,使用逻辑回归估计调整后的比值比(aOR),并通过 Bonferroni 校正(<0.00034)来衡量显著性。
对照组中分别有 8.40%、3.45%和 0.78%的人患有过敏性鼻炎、哮喘和湿疹。对于过敏性鼻炎,与下咽癌、食管(鳞状细胞癌)、宫颈癌、扁桃体/口咽癌和阴道/外阴癌存在强烈的负相关(aOR,0.66-0.79)。对于食管癌(腺癌)、胃癌、结肠癌、直肠乙状结肠/直肠、肝癌、胆囊癌、肺癌、子宫癌、膀胱癌和其他部位癌症,也观察到了更为适度但显著的负相关。需要配药来确认过敏性鼻炎存在的分析中,相关性更强。哮喘与肝癌风险降低相关(aOR 0.82;95%置信区间[CI],0.75-0.91),而湿疹与 T 细胞淋巴瘤风险升高相关(aOR,4.12;95%CI,3.43-4.95)。
过敏性鼻炎与多种癌症存在负相关,需要进行病因学研究。
了解过敏症降低癌症风险的机制可能会促进癌症的预防和治疗。